(Q45119447)

9 December 2017

title

Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer (English)

1 reference

9 December 2017

1 reference

Jian Qiu

1

1 reference

9 December 2017

Yanping Yu

2

1 reference

9 December 2017

Yunfeng Fu

3

1 reference

9 December 2017

Feng Ye

4

1 reference

9 December 2017

Xing Xie

5

1 reference

9 December 2017

Weiguo Lu

6

1 reference

9 December 2017

publication date

13 March 2012

1 reference

Journal of Obstetrics and Gynaecology Research

9 December 2017

published in

1 reference

9 December 2017

volume

38

1 reference

9 December 2017

issue

4

1 reference

9 December 2017

page(s)

651-657

1 reference

Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Significance of thrombocytosis in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Procoagulant mechanisms in tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01780.X

10.1111/J.1447-0756.2011.01780.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference